WSR 14-02-070 EXPEDITED RULES DEPARTMENT OF HEALTH (Board of Optometry) [Filed December 27, 2013, 2:19 p.m.]
Title of Rule and Other Identifying Information: WAC 246-851-610 Approval or removal of medications, changing board of pharmacy references to pharmacy quality assurance commission.
NOTICE
THIS RULE IS BEING PROPOSED UNDER AN EXPEDITED RULE-MAKING PROCESS THAT WILL ELIMINATE THE NEED FOR THE AGENCY TO HOLD PUBLIC HEARINGS, PREPARE A SMALL BUSINESS ECONOMIC IMPACT STATEMENT, OR PROVIDE RESPONSES TO THE CRITERIA FOR A SIGNIFICANT LEGISLATIVE RULE. IF YOU OBJECT TO THIS USE OF THE EXPEDITED RULE-MAKING PROCESS, YOU MUST EXPRESS YOUR OBJECTIONS IN WRITING AND THEY MUST BE SENT TO Judy Haenke, Program Manager, Department of Health, Board of Optometry, P.O. Box 47852, Olympia, WA 98504-7852, AND RECEIVED BY March 24, 2014.
Purpose of the Proposal and Its Anticipated Effects, Including Any Changes in Existing Rules: The proposal changes board of pharmacy references in WAC 246-851-610 to pharmacy quality assurance commission.
Reasons Supporting Proposal: HB 1609 (chapter 19, Laws of 2013), which became effective July 28, 2013, changed the title and reference of the board of pharmacy to the pharmacy quality assurance commission. This rule is being proposed under an expedited rule-making process because the proposed rule corrects the name only and does not change the effect of the rule or add any additional requirements.
Statutory Authority for Adoption: RCW 18.54.070(2).
Statute Being Implemented: HB 1609 (chapter 19, Laws of 2013).
Rule is not necessitated by federal law, federal or state court decision.
Name of Proponent: Department of health, board of optometry, governmental.
Name of Agency Personnel Responsible for Drafting, Implementation and Enforcement: Judy Haenke, Program Manager, 111 Israel Road S.E., Tumwater, WA 98501, (360) 236-4947.
December 27, 2013
Kirby Putscher
Acting Executive Director
AMENDATORY SECTION (Amending WSR 04-12-127, filed 6/2/04, effective 7/3/04)
WAC 246-851-610 Approval or removal of medications.
The board((s)) of optometry and pharmacy quality assurance commission will use a joint process to determine changes to the oral drug list that includes a means to resolve disagreements. (1) Categories of medications approved by the Food and Drug Administration may be added to WAC 246-851-580(1) by rule through consultation and approval of the board of optometry and ((board of)) pharmacy quality assurance commission. (2) Medications approved by the Food and Drug Administration in categories that are within the scope of optometric physician practice that are not included in WAC 246-851-580(1) may be added through consultation and approval of the board of optometry and the ((board of)) pharmacy quality assurance commission. Approval will follow the joint process established by ((both boards)) the board and commission. (3) WAC 246-851-580 and 246-851-590 may be updated to reflect additions or removal of medications.
|